Posts by: Kara Elam

Kara Elam

Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.

March 31, 2015November 6, 2015

Study’s Findings on Asthma Do Not Support the “Hygiene Hypothesis”

Asthma, News

Since its theoretical inception, the hygiene hypothesis has become a widely accepted explanation for the swift rise in the number of children with allergic disorders and asthma in the developed ... Read more

March 25, 2015November 5, 2015

Study Highlights Impact of Changing CF Patient Demographics on Health Care Services Throughout Europe and the UK

Cystic Fibrosis, News

An article published this week in the new edition of the European Respiratory Journal provides a probable estimate of the number of children and adults with cystic fibrosis (CF) in 34 ... Read more

March 12, 2015October 28, 2015

Study Finds Evidence that the Presence of Emphysema on a CT Scan Increases Lung Cancer Risk

Emphysema, News

Dr. Claudia I. Henschke, MD, PhD, the Director of the Lung Screening Program and clinical professor of radiology at Mount Sinai Hospital, and her team of collaborating investigators, recently published an ... Read more

March 10, 2015November 5, 2015

Researchers Review Importance of Non-Invasive Imaging in Diagnosis and Management of PAH

News, Pulmonary Hypertension

A recently accepted manuscript on the Canadian Journal of Cardiology, an open access journal, provides an overview of the current clinical use of noninvasive imagining techniques, such as echocardiography, for pulmonary ... Read more

March 9, 2015November 5, 2015

Results of SERAPHIN Trial Show Macitentan PAH Treatment Decreases Hospitalization Risk

News, Pulmonary Hypertension

A group of international pulmonary medical specialists have conducted a clinical trial to assess improvement in hospital based outcomes in patients with pulmonary arterial hypertension (PAH) when treated with macitentan, ... Read more

March 6, 2015March 6, 2015

PH Due to Langerhans Cell Histiocytosis May Benefit from Common PH Therapy, Case Study Shows

News

Researchers at the Mayo Clinic, Rochester, MN, published a clinical case study in which a novel therapeutic approach showed promising results in treating a fairly uncommon lung disease, known as ... Read more

February 25, 2015February 25, 2015

Austin Based Savara Pharmaceuticals AeroVanc Shows Promising Results in Combating MRSA in Cystic Fibrosis Patients

News

Savara Pharmaceuticals, an Austin based pharmaceutical company specializing in innovative drug development and delivery methods to treat life-threatening and rare respiratory diseases, recently announced that their leading product, AeroVanc, has ... Read more

February 16, 2015November 5, 2015

SteadyMed Preps for IPO to Fund PAH Drug Delivery Commercialization

News, Pulmonary Hypertension

SteadyMed Therapeutics, an Israeli based specialty pharmaceutical company that focuses on the development of drug product candidates to treat rare and chronic diseases with unmet parenteral (not delivered via the ... Read more

February 13, 2015November 6, 2015

Apricus Biosciences Announces Patent Award for RayVa Investigational Scleroderma Therapy

Scleroderma

Last October, Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, announced that The United States Patent and Trademark Office (USPTO) had issued a Notice of ... Read more

February 4, 2015November 9, 2015

Enrollment Completed for Phase 2 Trial of Aquinox Pharmaceuticals’s Potential New Drug to Treat COPD Exacerbations

COPD, News

Aquinox Pharmaceuticals, a Canadian based pharmaceutical company that focuses on the discovery and development of drug therapies for cancer and inflammatory conditions, announced on Monday that they had reached their ... Read more